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Copyright © 200? JCBN Summary Abietic acid (AA), the main component of the rosin fraction of oleoresin
synthesized by conifer species, has been reported to have anti-inflammatory effects. AA is a
weak contact allergen; however, compounds resulting from its oxidation by air elicit stronger
allergic response. Hydrogenation of the conjugated double bonds of AA, as in tetrahydro-
abietic acid (THAA), decreases its susceptibility to air oxidation and would thus reduce the
allergenicity of AA. The aim of this study was to investigate whether THAA could exert
anti-inflammatory effects to the same extent as AA in RAW264.7 macrophages activated
with the endotoxin lipopolysaccharide (LPS). THAA and AA inhibited the production of nitric
oxide (NO) and prostaglandin E2 by suppressing the expression of inducible NO synthase and
cyclooxygenase-2, respectively, in LPS-activated RAW264.7 macrophages. They also inhibited
the LPS-induced production of interleukin (IL)-1β, IL-6, and tumor necrosis factor-α. Both
THAA and AA prevented the LPS-induced nuclear translocation of the nuclear factor-κB/p65
subunit, suggesting that THAA may inhibit the production of pro-inflammatory mediators
through the same mechanism as AA. In comparison, the anti-inflammatory effects of THAA
and AA were almost identical, indicating that THAA retains the anti-inflammatory activity of
AA at least in LPS-activated RAW264.7 macrophages.
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Introduction
Inflammation is a complex process regulated by a variety
of immune cells and effector molecules. Among the immune
cells, activated macrophages play key roles in the initiation
and amplification of inflammation in a variety of inflamma-
tory diseases via the excess production of pro-inflammatoryN.-H. Kim et al.
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cytokines, including tumor necrosis factor-α (TNF-α),
interleukin-1β (IL-1β), and IL-6, and also the prolonged
expression of inducible pro-inflammatory enzymes, including
inducible nitric oxide synthase (iNOS) and cyclooxygenase-
2 (COX-2) [1]. The iNOS and COX-2, once expressed in
activated macrophages, can synthesize large amount of
nitric oxide (NO) and prostaglandin E2 (PGE2), respectively,
for a long period [2]. Lipopolysaccharide (LPS), a principal
component of the outer membrane of Gram-negative bacteria,
activates macrophages to produce these inflammatory medi-
ators mainly through activation of nuclear factor (NF)-κB
[3]. The transcription factor, NF-κB, exists mainly as a
heterodimer consisting of subunits of the Rel family p50 and
p65, which are normally sequestered in the cytosol as an
inactive complex due to binding with inhibitor proteins in
unstimulated cells [4]. The activation of NF-κB by LPS in
macrophages results in phosphorylation, ubiquitination,
and proteasome-mediated degradation of the inhibitory pro-
teins, followed by the translocation of p50/p65 heterodimer
to the nucleus and the induction of transcriptions of pro-
inflammatory mediators through binding to their binding
sites in the promoter regions of target genes [5]. There are
many studies demonstrating that naturally occurring phyto-
chemicals, such as terpenoids and flavonoids, can inhibit
the production of macrophage-mediated pro-inflammatory
mediators via inhibition of NF-κB activation (reviewed in
Ref. [6] and see references therein), and the compounds thus
are considered to have anti-inflammatory effects.
Terpenoids, which are present in many dietary and herbal
plants [7], have been regarded as valuable medicinal and
food components that may regulate many cellular functions.
Abietic acid (AA), a tricyclic diterpene carboxylic acid
(chemical structure shown in Fig. 1), is the main component
of the rosin fraction of oleoresin synthesized by conifer
species, such as grand fir (Abies grandis) and lodgepole
pine (Pinus contorta) [8]. AA is a weak contact allergen;
however, compounds resulting from its oxidation by air
elicit stronger allergic response [9]. Hydrogenation of the
conjugated double bonds of AA, as in tetrahydroabietic acid
(THAA; chemical structure shown in Fig. 1), decreases its
susceptibility to air oxidation [10] and would thus reduce the
allergenicity of AA.
Studies on the pharmacological activities of AA have
demonstrated that AA suppresses the expression of pro-
inflammatory enzymes and inhibits the production of pro-
inflammatory cytokines in LPS-activated macrophages [11,
12]. However, whether THAA, even with its decreased
allergenicity, could also exert the anti-inflammatory effects
similar to those of AA remains to be investigated. The
present study, therefore, was undertaken to evaluate the anti-
inflammatory effects of THAA in RAW264.7 macrophages




AA and THAA were purchased from Wako Pure Chemical
Industries (Osaka, Japan). Dulbecco’s modified Eagle’s
medium (DMEM), LPS (Escherichia coli 055:B5), and 3-
(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide
(MTT) were purchased from Sigma-Aldrich (St. Louis,
MO). Antibodies against iNOS, COX-2, p65, phospho (p)-
IκB, IκBα, and β-actin were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA). The Enzyme-linked
immunosorbent assay (ELISA) kits for PGE2, TNF-α, IL-1β,
and IL-6 were purchased from R&D Systems (Minneapolis,
MN).
Cell culture
RAW264.7 macrophages were obtained from the American
Type Culture Collection (Manassas, VA). The cells were
cultured in DMEM supplemented with 2 mM glutamine,
antibiotics (100 U/ml of penicillin A and 100 U/ml of
streptomycin) and 10% heat-inactivated fetal bovine serum
(Gibco/BRL, Rockville, MD) and maintained at 37°C in a
humidified incubator containing 5% CO2.
Cell viability assay
Cell viability was determined by a modified MTT reduc-
tion assay. MTT is a pale yellow substance that is reduced
by living cells to yield a dark blue formazan product. This
process requires active mitochondria, and even fresh dead
cells do not reduce significant amounts of MTT. RAW264.7
macrophages were cultured in a 96-well flat-bottom plate at
concentration of 5 × 105 cells/ml. After 12 h of precondi-
tioning, the cells were treated with various concentrations
of THAA or AA for 24 h. Thereafter, culture medium was
aspirated and 100 μl of MTT dye (1 mg/ml in phosphate-
buffered saline) was added; the cultures were incubated for
4 h at 37°C. The formazan crystals produced through dye
reduction by viable cells were dissolved using acidified
isopropanol (0.1 N HCl). Index of cell viability was calcu-
Fig. 1. Chemical structures of abietic acid and tetrahydroabietic
acid.Anti-Inflammatory Effects of Tetrahydroabietic Acid
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lated by measuring the optical density of color produced by
MTT dye reduction at 570 nm.
Nitrite assay
The nitrite concentration in the medium was measured as
an indicator of NO production according to the Griess reac-
tion. One hundred microliters of each supernatant was mixed
with the same volume of Griess reagent (1% sulfanilamide
in 5% phosphoric acid and 0.1% naphthylethylenediamine
dihydrochloride in water); absorbance of the mixture at
550 nm was determined with an ELISA plate reader.
PGE2 assay
RAW264.7 macrophages were cultured in 24-well plates
and were incubated with LPS in the presence or absence of
AA or THAA for 24 h. One hundred microliters of superna-
tant of culture medium was collected for the determination
of PGE2 concentrations by ELISA.
Western blot analysis
RAW264.7 macrophages were incubated with or without
reagents. They were harvested, washed ice-cold phosphate-
buffered saline (PBS) and kept on ice for 1 min. The suspen-
sion was mixed with buffer A (10 mM HEPES, pH 7.5,
10 mM KCl, 0.1 mM EGTA, 0.1 mM EDTA, 1 mM DTT,
0.5 mM PMSF, 5 μg/ml aprotinin, 5 μg/ml pepstatin, and
10 μg/ml leupeptin) and lysed by three freeze-thaw cycles.
Cytosolic fraction was obtained by centrifugation at
12,000 × g for 20 min at 4°C. The pellets were re-suspended
in buffer C (20 mM HEPES, pH 7.5, 0.4 M NaCl, 1 mM
EGTA, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, 5 μg/ml
aprotinin, 5 μg/ml pepstatin, and 10 μg/ml leupeptin) on ice
for 40 min and centrifuged at 14,000 × g for 20 min at 4°C.
The resulting supernatant was used as soluble nuclear frac-
tion. Protein content was determined with BCA protein
assay reagent (Pierce, Rockford, IL). Total cellular or nuclear
fractions were separated on 10% SDS-polyacrylamide gels,
and transferred to the nitrocellulose membranes (Amersham
Biosciences, Inc., Piscataway, NJ). The membrane was then
blocked in blocking buffer containing 20 mM sodium phos-
phate buffer, pH 7.6, 150 mM NaCl, 0.1% Tween 20, and
5% nonfat dry milk for 1 h at room temperature. Thereafter,
the membrane was incubated with antibodies against iNOS
(1:1000 dilution), COX-2 (1:1000 dilution), p65 (1:500
dilution), or β-actin (1:1000 dilution) at 4°C overnight. The
membrane was then washed four times with PBS-Tween 20
buffer and further incubated with secondary antibody for 1 h
at room temperature. Specific bands were detected using
enhanced chemiluminescence detection system (Amersham
Biosciences), and the membrane was exposed to X-ray film.
Cytokine assay
RAW264.7 macrophages (5 × 105 cells/ml) were plated
onto 24-well plates and pretreated with 5, 10, 20, or 40 μg/ml
of THAA or AA for 1 h and then stimulated with 1 μg/ml of
LPS for 24 h. The cell supernatants were collected and
stored at −20°C until they were assayed for cytokines. The
concentrations of TNF-α, IL-1β, and IL-6 in the cell super-
natants were measured by ELISA kits according to the
manufacturer’s instructions.
NF-κB/p65 transcription factor assay
NF-κB activity was determined with the TransAM®
transcription factor assay kit (Active Motif, Carlsbad, CA)
following the manufacturer’s protocol. In brief, 5 μg of
nuclear extract was added to each well of a 96-well plate
precoated with NF-κB consensus binding oligonucleotide
(5'-GGGACTTTCC-3'). After 1 h of incubation with smooth
agitation, wells were washed three times with washing
buffer and then incubated with p65 antibody (dilution
1:1000) for 1 h at 20°C. After three successive washings,
the wells were incubated for 1 h with dilute horseradish
peroxidase-conjugated antibody (dilution 1:1000) followed
by the addition of 100 μL of developing solution. After
5 min of incubation, the reaction was blocked by adding
100 μL of stop solution reagent. Optical density was deter-
mined using spectrophotometer at 450 nm with a reference
wavelength of 655 nm.
Statistical analysis
Data were analyzed using Student’s t test, one-way analysis
of variance or Newman-Keuls multiple comparison test. If
not otherwise stated, data are expressed as means ± SD from
three independent experiments. Differences were considered
significant when p<0.01.
Results
The cytotoxic effects of AA and its analogue, THAA, were
evaluated in the presence or absence of LPS (1 μg/mL), and
neither AA nor THAA reduced the cell viability of
RAW264.7 macrophages in the absence of LPS even at a
dose of 80 μM after a period of 24 h (Fig. 2). Interestingly,
both AA and THAA blocked the cell death induced by LPS
stimulation; the cytoprotective effects of the compounds
were most significantly observed at 40 μM of each com-
pound (Fig. 2). At non-cytotoxic concentrations (5–40 μM),
both AA and THAA markedly reduced LPS-induced NO
production in a dose-dependent manner (Fig. 3A). To examine
whether AA and THAA could also inhibit PGE2 production,
RAW264.7 macrophages were pre-incubated with various
concentrations of AA or THAA for 1 h, and then activated
with LPS (1 μg/mL) for 24 h. As shown in Fig. 3B, both AA
and THAA significantly inhibited the production of PGE2 in
a dose-dependent manner. We next determined whether the
inhibitory effects of AA and THAA on the production of NON.-H. Kim et al.
J. Clin. Biochem. Nutr.
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and PGE2 could be related to the modulation of the expres-
sion of the iNOS and COX-2 enzymes. In unstimulated
RAW264.7 macrophages, neither iNOS nor COX-2 protein
was detectable. In response to LPS, the expression levels of
iNOS and COX-2 were markedly augmented, and AA
significantly inhibited iNOS and COX-2 expression in a
dose-dependent manner (Fig. 4A). Similar results were also
observed when the effects of THAA on the LPS-induced
iNOS and COX-2 expression were examined (Fig. 4B). In
general, these results are consistent with the profile of the
inhibitory effects of AA and THAA on NO and PGE2
production. We further investigated the effects of AA and
Fig. 2. Effects of AA and THAA on the cell viability of RAW264.7 macrophages. Cells were incubated with indicated concentrations
of either AA (A) or THAA (B) in the absence or presence of 1 μg/mL of LPS for 24 h. The cell viability was determined by
MTT assay, as described in Materials and Methods. *p<0.05 as compared with the control group (cultured in medium alone).
**p<0.05 as compared with only LPS groups.
Fig. 3. Effects of AA and THAA on the production of NO and PGE2 in LPS-activated RAW264.7 macrophages. Cells were pretreated
with indicated concentrations of AA or THAA for 1 h prior to the addition of 1 μg/mL of LPS, and the cells were further
incubated for 24 h. The concentrations of nitrite (A) and PGE2 (B) in culture medium were determined by Griess reaction and
PGE2 ELISA kit, respectively, as described in Materials and Methods. *p<0.05 as compared with the control group (cultured in
medium alone). **p<0.05 as compared with only LPS groups.Anti-Inflammatory Effects of Tetrahydroabietic Acid
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THAA on the LPS-induced production of TNF-α, IL-1β,
and IL-6 by using an enzyme immunoassay. Pre-treatment
of RAW264.7 macrophages with AA or THAA for 1 h
decreased the production of these pro-inflammatory cyto-
kines in a dose-dependent manner (Fig. 5A, B and C).
Finally, we investigated whether AA and THAA could
prevent the translocation of the subunit of NF-κB, p65, from
the cytosol to the nucleus after its release from its inhibitory
proteins. In the case of the treatment with 40 μM of AA, a
decrease in the level of p65 in the nuclear fraction was
detected by Western blot analysis (Fig. 6A). This cascade
was also confirmed by the inhibition of the NF-κB/p65
DNA binding activity after 2 h treatment with AA (Fig. 6B).
Similarly, THAA (40 μM) also prevented the translocation
of NF-κB/p65 from the cytosol to the nucleus (Fig. 6A and
B). The IκB kinase (IKK) pathway was examined as another
potential regulator of NF-κB. Both AA and THAA inhibited
IκBα degradation resulting from LPS stimulation (Fig. 6C).
In addition, IκBα phosphorylation (p-IκB) in RAW264.7
macrophages increased after LPS treatment, and this phos-
phorylation was also inhibited by AA or THAA (Fig. 6C).
Discussion
It has been reported that AA has anti-inflammatory effects
[11, 12]. Unfortunately, the conjugated double bonds of AA
Fig. 4. Effects of AA and THAA on the expression of iNOS and COX-2 in LPS-activated RAW264.7 macrophages. Cells were
pretreated with indicated concentrations of AA (A) or THAA (B) for 1 h prior to the addition of 1 μg/mL of LPS, and the cells
were further incubated for 6 h. The levels of iNOS and COX-2 proteins were monitored by Western blot analysis as described in
Materials and Methods. These experiments have been repeated three times with similar observation.
Fig. 5. Effects of AA and THAA on the production of TNF-α, IL-1β, and IL-6 in LPS-activated RAW264.7 macrophages. Cells were
pretreated with indicated concentrations of AA or THAA for 1 h prior to the addition of 1 μg/mL of LPS, and the cells were
further incubated for 24 h. The concentrations of TNF-α (A), IL-1β (B), and IL-6 (C) in culture medium were determined by
their specific antibody-coated ELISA kits as described in Materials and Methods. *p<0.05 as compared with the control group
(cultured in medium alone). **p<0.05 as compared with only LPS groups.N.-H. Kim et al.
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are readily oxidized by air and its oxidation products are
considered to be responsible for the allergenic effect [9].
THAA, a modified AA analogue that is reduced by hydro-
genation of two double bonds, is much more resistant to air
oxidation than AA [10]. Whether THAA could exert anti-
inflammatory effects to the same extent as AA, however, has
not been investigated so far. The present study demonstrates,
for the first time, that THAA can suppress the expression of
pro-inflammatory enzymes (iNOS and COX-2) and inhibit
the production of pro-inflammatory cytokines (IL-1β, IL-6,
and TNF-α) through inhibition of NF-κB activation in LPS-
activated RAW264.7 macrophages.
NO, PGE2, and pro-inflammatory cytokines (e.g., IL-1β,
IL-6, and TNF-α) have been implicated as important inflam-
matory mediators in the process of macrophage-mediated
inflammation [13,  14]. However, the uncontrolled/excess
production of these mediators by activated macrophages
may contribute to the development of various inflammatory
diseases [15]. Hence, the inhibition of these mediators by
pharmacological modulators may be an effective therapeutic
strategy for preventing inflammatory reaction and diseases
[16]. The present study demonstrates that THAA at non-
cytotoxic doses inhibited the production of NO and PGE2 in
LPS-activated RAW264.7 macrophages. To search for the
underlying mechanism of this potent effect of THAA, we
examined its effects on the protein expression levels of
both iNOS and COX-2 enzymes, which are responsible for
NO and PGE2 production. We found that THAA suppressed
LPS-induced iNOS and COX-2 expression, suggesting that
the inhibition of NO and PGE2 production by THAA is a
result of the inhibition of iNOS and COX-2 expression. In
other experimental sets, we also examined whether THAA
could inhibit the production of pro-inflammatory cytokines
in LPS-stimulated RAW264.7 macrophages. Similar to its
inhibitory effects on the expression of pro-inflammatory
enzymes, THAA inhibited the production of TNF-α, IL-1β,
and IL-6. Thus, our results suggest that THAA, at least in
LPS-activated macrophages, may exert the anti-inflammatory
effects not only by suppressing the expression of pro-
inflammatory enzymes but also by inhibiting the production
of pro-inflammatory cytokines.
In our study, we also performed a comparative study of
the anti-inflammatory effects of AA and THAA at the
same concentration, and found that THAA had almost the
same inhibitory effects as AA on the production of pro-
inflammatory mediators in LPS-activated RAW264.7 macro-
phages, indicating that the presence of the conjugated double
bonds of AA is not essential for anti-inflammatory activity;
i.e., the hydrogenation of these bonds results in no significant
effect on the anti-inflammatory activity of AA. Moreover,
both THAA and AA effectively blocked the activity of
NF-κB, a key transcription factor that can induce the expres-
sion of pro-inflammatory enzymes and cytokines, and their
inhibitory effects on NF-κB activation were almost identical,
suggesting that both THAA and AA may inhibit the produc-
tion of the inflammatory mediators, presumably through the
mechanism(s) associated with NF-κB inactivation. Thus,
our results confirm that THAA, a reduced AA analogue with
higher oxidative stability than AA [10], retains the anti-
inflammatory activity of its parent compound, AA.
Under normal conditions, NF-κB associates with inhibitory
IκB proteins which sequester NF-κB in the cytoplasm.
Fig. 6. Effects of AA and THAA on the nuclear translocation of NF-κB/p65 in LPS-activated RAW264.7 macrophages. Cells were
treated with 40 μM of either AA or THAA for 1 h prior to the addition of 1 μg/mL of LPS, and the cells were further incubated
for 2 h. The levels of cytosol and nuclear NF-κB/p65 proteins (A) and proteins of IκBα and p-IκB (C) were monitored by West-
ern blot analysis as described in Materials and Methods. These experiments have been repeated three times with similar obser-
vation. The NF-κB/p65 DNA-binding activities (B) were measured by NF-κB/p65 transcription factor assay kit as described in
Materials and Methods. *p<0.05 as compared with the control group (cultured in medium alone). **p<0.05 as compared with
only LPS groups.Anti-Inflammatory Effects of Tetrahydroabietic Acid
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Phosphorylation of IκB by IκB kinases (IKKs) is required to
release NF-κB from this inhibition [4]. Indeed, LPS stimula-
tion of RAW264.7 macrophages activates several intra-
cellular signaling pathways, including the IκB kinase (IKK)/
NF-κB pathway [17]. Our results suggest that both AA and
THAA impinge on the IKK pathway to dampen the inflam-
matory response by repressing IκB phosphorylation and
subsequent NF-κB activation (Fig. 6). Accordingly, the
inhibition of IκB phosphorylation and degradation by AA or
THAA during LPS-induced inflammation may limit NF-κB
activation.
Conclusion
The data presented in this study lead to the following
major conclusions: (i) in addition to AA, THAA, a reduced
analogue of AA, is also able to inhibit the production of
NO and PGE2 by suppressing the expression of iNOS and
COX-2 as well as the production of pro-inflammatory cyto-
kines (IL-1β, IL-6, and TNF-α) in LPS-activated RAW264.7
macrophages; (ii) both THAA and AA prevent the nuclear
translocation of NF-κB/p65, presumably suggesting that
THAA may exert anti-inflammatory effects through the
same mechanism as AA; (iii) the anti-inflammatory effects
of THAA and AA are almost identical, indicating that
THAA retains the anti-inflammatory activity of AA.
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